The Safety of Hyperbaric Oxygen Therapy in the Treatment of Covid-19
Relevance. Acute respiratory infection COVID-19 caused by the SARS-CoV-2 (2019-nCov) coronavirus is severe and extremely severe in 15—20% of cases, which is accompanied by the need for respiratory support. Hyperbaric oxygenation is recognized as an effective therapy for replenishing any form of oxyg...
Main Authors: | O. A. Levina, A. K. Еvseev, A. K. Shabanov, V. V. Kulabukhov, N. Y. Kutrovskaya, I. V. Goroncharovskaya, K. A. Popugaev, D. A. Kosolapov, D. S. Slobodeniuk, S. S. Petrikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2020-10-01
|
Series: | Неотложная медицинская помощь |
Subjects: | |
Online Access: | https://www.jnmp.ru/jour/article/view/923 |
Similar Items
-
Hyperbaric Oxygen Therapy in Patients with COVID-19
by: S. S. Petrikov, et al.
Published: (2020-12-01) -
Hyperbaric oxygenation in transplantology
by: O. A. Levina, et al.
Published: (2020-03-01) -
HYPERBARIC OXYGEN THERAPY (HBOT) AS THE TREATMENT OF PROLONGED HYPOXEMIA DUE TO COVID-19
by: Diana Paskaleva, et al.
Published: (2023-10-01) -
Use of hyperbaric oxygenation in the combination therapy of posttransplant kidney patients in the early postoperative period
by: M. V. Romasenko, et al.
Published: (2018-08-01) -
HISTORICAL DEVELOPMENT OF THE HYPERBARIC OXYGENATION
by: Krasimira Tsankova, et al.
Published: (2021-06-01)